Necrotiserende otitis externa – osteomyelitis schedelbasis

Initiatief: NVKNO Aantal modules: 10

Surgical treatment

Uitgangsvraag

What is the added value of surgical treatment, compared to medical treatment only, for necrotizing otitis externa?

Aanbeveling

Treat patients with necrotizing otitis externa medically. There is no role for surgery as the primary treatment for patients with necrotizing otitis externa.

 

In the following scenarios a surgical approach can be chosen, apart from medical treatment: 

  • In case of failing treatment. A surgical approach for diagnostic purposes can be undertaken to improve the chance of a positive culture, or to exclude a different diagnosis. Ablative surgery as salvage treatment is not advised.
  • No advise is given on the role for surgery in case of facial nerve palsy, due to the limited evidence.

Take into account that most patients with necrotizing otitis externa are frail. The risk of general anesthesia should also be considered and weighed in the (shared) decision making.

Overwegingen

Balance between desired and undesired effects

The systematic literature search yielded conflicting results in the few selected articles. Only one RCT was identified, which favored surgery for treatment response in patients with refractory necrotizing otitis externa who were unsuccessfully treated with antibiotics for 6 weeks. However, the methodological and statistical approaches were questionable (Singh, 2018). An observational study on the primary treatment of necrotizing otitis externa found no clinically relevant improvement in remission rates favoring surgical treatment over antibiotics alone (RR 1.15, 95% CI: 0.84 to 1.55) (Lambor, 2013).

 

Current literature cannot provide a clear answer regarding the role of surgery in necrotizing otitis externa. This is partly due to the rarity of the condition and partly because the cornerstone of treatment is medical. Recent trends also show a sharp decline in the use of extensive surgical therapy for the disease (which included mastoidectomy, facial nerve decompression, and/or middle ear exploration), with 13.3% of patients undergoing extensive surgery before 2009 compared to 3.7% after 2009 (Byun, 2020).

 

A variety of surgical options are described in the literature, ranging from nettoyage of the ear canal to lateral temporal bone resection. Based on the literature search, it is evident that no clear surgical indication exists. However, specific procedures could be considered for different indications. This list is explicitly not a hierarchical ste-by-step enumeration of treatment options; it is a list of treatment options that is opted for in literature in specific conditions.

 

  • Nettoyage of the ear canal: This can be performed in combination with obtaining culture material or tissue biopsy for diagnostic purposes. Cleaning the ear canal of debris might not be considered a surgical intervention, but it is mentioned because it is reported in literature as (part of) a treatment.
  • Other studies describe more extensive surgical interventions of the ear canal, including sequestrectomy and smoothing of bony irregularities / canalplasty. In our opinion, it is important not to confuse NOE with osteitis of the temporal bone for this indication. Osteitis due to a localized infection and/or inflammation can be a major cause of sequestra and epithelial defects in the ear canal, leading to granulation tissue and loss of the canal's migratory capacity. Moreover, prior radiotherapy of the parotid gland or nasopharynx can cause avascular necrosis or osteoradionecrosis of the temporal bone, leading to tissue defects as mentioned earlier, which can mimic NOE. Again, this should not be confused with NOE, especially because the nature of this problem is not primarily infectious.
  • Mastoidectomy: The guideline panel believes that the main incentive for this procedure would be diagnostic, as local treatment of the ear canal might not reveal pathogens. Local epithelialization in the ear canal may be restored due to local treatment, whereas the infectious process can progress in deeper tissues. Mastoidectomy solely to reduce infectious load has been described but is considered obsolete.
  • (Sub)total petrosectomy/lateral temporal bone resection: The most invasive type of surgery consists of (sub)total petrosectomy or lateral temporal bone resection. No evidence supports the indication for these procedures. These types of surgery could be considered as salvage surgery if all other treatments fail, potentially aiding in reducing disease burden. However, morbidity and mortality rates are high, making these procedures generally discouraged (Peleg, 2007; Omran, 2012).
  • Facial nerve decompression: Facial nerve decompression in cases of facial nerve palsy is described as an indication for surgical intervention, with one study reporting its positive effects (Freeman, 2023). Facial nerve decompression is automatically performed in combination with mastoidectomy due to the surgical approach.

The extent of surgical intervention, if any, depends on multiple factors. Moreover, a combination of procedures can be chosen if indicated. The most obvious surgical indication is the search for a causative pathogen, especially in cases of failed initial medical treatment. Imaging can guide the determination of the anatomical area to approach for tissue sampling. The ear canal, mastoid, and skull base can be areas of interest, and occasionally the nasopharynx, if affected, is easily accessible.

 

Given the sparse literature available, it is difficult to provide clear recommendations. If no pathogen is identified, antibiotic treatment cannot be optimized, surgical intervention should be considered. The type of surgery will be determined on an individual basis and depends on multiple factors. Imaging reveals which areas are affected, guiding the choice of surgery. The clinical state of the patient, as well as cranial nerve involvement, is weighed in the decision to perform surgery. If there is a suspicion of malignancy tissue samples need to be obtained, and more invasive surgery might be necessary to collect relevant tissue samples. Unequivocally, antibiotic treatment will remain the primary treatment modality in case of NOE. Studies to determine the benefit of surgical interventions will continue to be challenging, as necrotizing otitis externa is rare and indications are unclear. However, a large multicenter study with clear indications might provide more insight into the role of surgery in the treatment of necrotizing otitis externa.

 

Quality of the evidence

The overall quality of evidence is very low. This means that the estimated effect of the critical outcomes that were found are very uncertain. There was a downgrade due to the following:

  • Risk of Bias: methodological limitations.
  • Inconsistency: inconsistency of the results.
  • Indirectness: indirectness of the evidence, due to differences in the use of surrogate outcomes.
  • Imprecision: inaccuracy, due to a very small number of events in a small sample size.

Moreover, the inconsistent terminology used in surgical approaches and the doubtful use of correct diagnoses might give a distorted image of literature, with a high risk of publication bias.

 

Values and preferences of patients (and possibly their caregivers)

Since studies describing surgery for necrotizing otitis externa are rare, it can be difficult to decide when to opt for surgery. Moreover, available reports are unclear and inconsistent regarding the type and extent of surgery. Patients should be informed about the goal of the procedure and the associated risks. The uncertainty of the outcome should also be addressed. The alternative to surgical intervention depends on the indication for the procedure. If the causative pathogen is unknown, surgery to obtain tissue samples is a reasonable indication. In cases of cranial nerve palsy, the indication and outcome are more uncertain, and both physicians and patients should be aware of this. If (optimal) conservative treatment does not result in clinical improvement, similar considerations must be made, and specialized (tertiary) centers should be consulted regarding further treatment.

 

Costs (resources)

Since surgery for NOE is rare, costs for this kind of treatment are negligible considering total treatment costs. However, no studies have been performed to show cost-effectiveness of the treatment, let alone for the surgery done in a small percentage of cases.

 

Equity ((health) equity/equitable)

The guideline panel expects no problems with health equity with regard to medical treatment of necrotizing otitis externa.

 

Acceptability

The guideline panel expects no problems with ethical acceptability or sustainability with regard to medical treatment of necrotizing otitis externa.

 

Feasibility

Regardless of the eventual recommendation, surgical intervention is feasible. The intervention is a treatment option for some clinicians. Even though the surgical procedure is feasible, the indication is complex, if existent, as mentioned before. Given this complexity the advice is to consult a specialist in NOE when surgery is considered in patients that do not seem to respond to conservative treatment. No specialized equipment is needed for surgical procedures.

 

Rationale of the recommendation: weighing arguments for and against the interventions

The literature on outcome or effect of surgical intervention as a standard treatment is of insufficient certainty and different studies all use different outcome measures. Therefore, the recommendations are expert opinions.

 

The available literature for surgical treatment in NOE suggests that surgery has a very limited role. The main indication for surgical exploration is in case of failing conservative treatment in case of an unknown causative pathogen.

 

There is insufficient available evidence on the effect of facial nerve decompression in case of facial nerve palsy in NOE.

 

Final judgment:

Weak recommendation against surgical intervention in patients with necrotizing otitis externa.

Onderbouwing

It is generally accepted that the treatment of necrotizing otitis externa (NOE) involves long-term administration of antibiotics (or antimycotics in the case of fungal infections). In specific scenarios, surgical treatment may be considered:

  • If no pathogen can be identified, surgery may be performed to obtain deep tissue samples. This is considered a diagnostic procedure rather than a curative treatment.
  • If there is no or insufficient response to medical treatment; this is also referred to as salvage surgery.
  • Surgery aimed at curing or preventing (further) damage to vital structures, such as the facial nerve or the inner ear.

Surgery in the infected area can be complex and carries risks, particularly in frail patients, which NOE patients often are.

PICO (1.1)

Population:       Patients with proven necrotizing otitis externa

Intervention:     Surgical treatment

Comparison:     Medical treatment

Outcome

Timeframe

Study results and measurements

Absolute effect estimates

Certainty of the Evidence

(Quality of evidence)

Summary

Medical treatment

Surgical treatment

 

Survival

 

1 study reported no mortality

-

Very low

By very serious imprecision2

The evidence is very uncertain about the effect of surgical management to improve survival in patients with skull base osteomyelitis.

 

 

(Freeman 2023)

Remission

 

The risk ratio (RR) is 1.15 (95% CI: 0.84 to 1.55), based on 27 participant from one study.

-

Very low

By very serious imprecision3

The evidence is very uncertain about the effect of surgical management to improve disease control in patients with skull base osteomyelitis.

 

(Lambor, 2013)

Quality of life

 

-

 

-

-

No evidence was found about the effect of surgical management to improve the quality of life in patients with skull base osteomyelitis.

1. Imprecision: very serious. Low population (<100)

2. Imprecision: very serious. Low population (<100)

3. Imprecision: very serious. Low population (<100)

Description of studies

A total of 3 studies were included in the literature analysis. Key study characteristics and results are summarized in Table 1. The risk of bias assessment is summarized in the risk of bias tables (under the tab ‘Evidence tables’). One RCT (Singh, 2018) and two observational studies (Omran, 2012; Freeman, 2023) were included. For details, See also Table 1 below.

 

Table 1. Characteristics of included studies

Study

Participants (number, age, other important characteristics)

Comparison

Follow-up

Outcome measures

Comments

Risk of bias (per outcome measure)*

Individual studies

Singh, 2018

N at baseline

Intervention: 10

Control: 10

 

Age

Means not reported. 30% were in age group 40–60 years. 70% were in age group 60–80 years.

 

Sex

14 males, 6 females

 

Relevant characteristic: Patients with refractory malignant necrotizing otitis externa; (no disease response after 6 weeks of oral ciprofloxacin).

 

Patients were randomized into two groups.

Group A: Patients received intravenous ceftazidime along with oral ciprofloxacin 750 mg twice daily and acetic acid washes three times a day.

Group B: Patients were started on oral ciprofloxacin 750 mg twice daily, combined with surgical intervention and regular postoperative care.

The aim of the surgical treatment was:

  1. Local debridement of necrotic tissue.
  2. Abscess drainage and creation of a drainage route.
  3. Control of complications.

 

Short follow-up (mean follow-up not described)

Remission

Type of study: RCT

Remission: High

Lambor, 2013

N at baseline

Intervention: 12

Control: 15

 

Age

between 50 and 80 years

(no mean)

 

Sex

22 males, 5 female

 

Intervention: Surgical intervention in addition to antibiotic treatment (see control)

 

Control: 3–4 weeks of parenteral antibiotics (depending on the antibiotic sensitivity

report) and the daily insertion of medicated (polymyxin B and neomycin sulphates ointment) wicks.

 

4-6 months after discharge.

No statistical analysis was performed in this study.

Type of study: Retrospective cohort study

Remission: High

Freeman, 2023

N at baseline

Intervention: 12

Control: 15

 

Patients were treated with medical therapy with or without surgical intervention:

 

Intervention was surgery, further divided into two groups:

 

alongside surgical debridement of the affected ear.

 

All patients received systemic antibiotics.

 

Control: Systemic antibiotics only.

The median length of

follow-up after the onset of facial palsy was 280 days.

Survival,

 

 

Type of study:

Retrospective cohort study

Survival: High

 

 

 

 

*For further details, see risk of bias table in the appendix

 

Results

Survival (critical)

Freeman (2023) reported no deaths in both surgical and medical groups.

 

Remission (critical)

One study reported remission as an outcome measure (Singh, 2018). However, the authors did not report remission as a dichotomous result. Instead, to compare the treatment responses, the number of resolutions per criterion per group was assessed: 

  1. Complete resolution of edema and granulation.
  2. Resolution of pain (nocturnal pain).
  3. Hearing loss resolution.
  4. No disease on post treatment gallium scan.
  5. Resolution of ear discharge.
  6. TM joint pain resolution.

Group A was the antibiotic group, and group B was the surgical group. To determine the preferred treatment for the overall best resolution of aforementioned criteria, a Mann–Whitney U test was applied, which found surgical treatment to be more effective. However, the exact methods are not specifically mentioned and are, therefore, not reproducible.

 

The number of patients with resolved disease on the post-treatment gallium scan were 6 out of 10 in group B versus 2 out of 10 in group A. The risk ratio (RR) was 3.0 (95% CI: 0.79 to 11.4), favoring the surgery group.

 

Lambor (2013) found a remission rate of 11 out of 12 in the surgery group and 12 out of 15 in the control group (Risk Ratio 1.12, 95% CI 0.85–1.55).

 

Quality of life (important)

None of the included studies reported quality of life as an outcome measure.

A systematic review of the literature was conducted to address the following question:
What are the benefits and disadvantages of surgical treatment for necrotizing otitis externa compared to medical treatment?

Patients Patients with proven necrotizing otitis externa
Intervention

Surgical treatment (with or without medical treatment)

Control Medical treatment
Outcomes (Disease specific) survival, remission, quality of life
Other selection criteria Study design: systematic reviews and randomized controlled trials 

Relevant outcome measures

The guideline panel considered remission, (disease-free) survival and disease control as  critical outcome measures for decision-making; and quality of life as an important outcome measure for decision making.

 

The guideline panel defined the outcome measures as follows:

  • Survival:
    • Overall survival: Time to death from any cause.
    • Disease free survival: Time to death, caused by the effects of necrotizing otitis externa/skull base osteomyelitis.
  • Remission: Rate of curation of disease, defined after prolonged disappearance of the signs and symptoms of a disease.
  • Health-related Quality of Life (HR-QoL): Preferably measured with EQ-5D-5L

The guideline panel defined the following as a minimal clinically (patient) important difference.

The guideline panel defined the following differences as a minimal clinically (patient) important difference.

  • Remission:  25% difference in relative risk (GRADE standard limits)*
  • Survival: 25% difference in relative risk (GRADE standard limits)*
  • Quality of life: 25% difference in relative risk or 0.5 standard deviations difference (GRADE standard limits)*

* Default thresholds proposed by the international GRADE working group were used: a 25% difference in relative risk (RR) for dichotomous outcomes (RR <0.80 or RR >1.25), or 0.5 standard deviations (SD) for continuous outcomes

 

Search and select (Methods)

The databases Medline (via OVID) and Embase (via Embase.com) were searched using relevant search terms from 2000 until February 6th, 2023. The detailed search strategy is provided under the tab ‘Literature Search Strategy’. The systematic literature search yielded 456 unique hits. Studies were selected based on the following criteria: systematic reviews, RCTs, observational studies, and other non-comparative research on the value of surgical treatment for necrotizing otitis externa. Forty-six studies were initially selected based on title and abstract screening. After full-text review, 43 studies were excluded (see the table with reasons for exclusion under the tab ‘Evidence Tables’), and 3 studies were included.

 

Results

Three studies, consisting of 1 RCT and 2 observational studies, were included in the literature analysis. Key study characteristics and results are summarized in the evidence tables. The risk of bias assessment is summarized in the risk of bias tables.

  1. Byun YJ, Patel J, Nguyen SA, Lambert PR. Necrotizing Otitis Externa: A Systematic Review and Analysis of Changing Trends. Otol Neurotol. 2020 Sep;41(8):1004-1011. doi: 10.1097/MAO.0000000000002723. PMID: 32569149.
  2. Freeman MH, Perkins EL, Tawfik KO, O'Malley MR, Labadie RF, Haynes DS, Bennett ML. Facial Paralysis in Skull Base Osteomyelitis - Comparison of Surgical and Nonsurgical Management. Laryngoscope. 2023 Jan;133(1):179-183. doi: 10.1002/lary.30161. Epub 2022 May 12. PMID: 35546515.
  3. Lambor DV, Das CP, Goel HC, Tiwari M, Lambor SD, Fegade MV. Necrotising otitis externa: clinical profile and management protocol. J Laryngol Otol. 2013 Nov;127(11):1071-7. doi: 10.1017/S0022215113002259. Epub 2013 Oct 29. PMID: 24169084.
  4. Omran AA, El Garem HF, Al Alem RK. Recurrent malignant otitis externa: management and outcome. Eur Arch Otorhinolaryngol. 2012 Mar;269(3):807-11. doi: 10.1007/s00405-011-1736-2. Epub 2011 Aug 11. PMID: 21833561.
  5. Peleg U, Perez R, Raveh D, Berelowitz D, Cohen D. Stratification for malignant external otitis. Otolaryngol Head Neck Surg. 2007 Aug;137(2):301-5. doi: 10.1016/j.otohns.2007.02.029. PMID: 17666260.
  6. Singh J, Bhardwaj B. The Role of Surgical Debridement in Cases of Refractory Malignant Otitis Externa. Indian J Otolaryngol Head Neck Surg. 2018 Dec;70(4):549-554. doi: 10.1007/s12070-018-1426-0. Epub 2018 Jun 18. PMID: 30464914; PMCID: PMC6224839.

Risk of Bias tables 

Risk of bias table for intervention studies (observational: non-randomized clinical trials, cohort and case-control studies

Study reference

 

 

(first author, year of publication)

Bias due to a non-representative or ill-defined sample of patients?1

 

 

(unlikely/likely/unclear)

Bias due to  insufficiently long, or   incomplete follow-up, or differences in follow-up between treatment groups?2

 

(unlikely/likely/unclear)

Bias due to ill-defined or inadequately measured outcome ?3

 

 

(unlikely/likely/unclear)

Bias due to inadequate adjustment for all  important prognostic factors?4

 

(unlikely/likely/unclear)

Lambor, 2013

Unlikely

Unlikely

likely

Unclear

Freeman, 2023

likely

unlikely

Likely

Unclear

Risk of bias table for intervention studies (randomized controlled trials; based on Cochrane risk of bias tool and suggestions by the CLARITY Group at McMaster University)

Study reference

 

(first author, publication year)

Was the allocation sequence adequately generated?

 

Was the allocation adequately concealed?

 

 

Blinding:

 

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of selective outcome reporting?

Was the study apparently free of other problems that could put it at a risk of bias?

 

Overall risk of bias

If applicable/necessary, per outcome measure

 

Singh, 2018

Definitely yes;

 

Reason: Central randomization with computer generated random numbers

Probably no

 

Reason: concealment of allocation was not reported in the article

Definitely no

 

Reason: Open-label trial (patients and health care providers not blinded), outcome assessors blinded (blinding of data collectors and analysts not reported)

Definitely yes.

 

Reason: no patients were lost to follow up.

definitely no;

 

Reason: only some symptoms reported, on which was decided that one therapy was better than the other.  

Definitely yes;

 

Reason: No other problems noted

HIGH (Disease control)

Table of excluded studies

Reference

Reason for exclusion

Das S, Iyadurai R, Gunasekaran K, Karuppusamy R, Mathew Z, Rajadurai E, John AO, Mani S, George T. Clinical characteristics and complications of skull base osteomyelitis: A 12-year study in a teaching hospital in South India. J Family Med Prim Care. 2019 Mar;8(3):834-839. doi: 10.4103/jfmpc.jfmpc_62_19. PMID: 31041210; PMCID: PMC6482749.

Wrong population (also including non otogenic)

Chawdhary G, Pankhania M, Douglas S, Bottrill I. Current management of necrotising otitis externa in the UK: survey of 221 UK otolaryngologists. Acta Otolaryngol. 2017 Aug;137(8):818-822. doi: 10.1080/00016489.2017.1295468. Epub 2017 Mar 16. PMID: 28301961.

No comparison made

Chawdhary G, Pankhania M, Douglas S, Bottrill I. Current management of necrotising otitis externa in the UK: survey of 221 UK otolaryngologists. Acta Otolaryngol. 2017 Aug;137(8):818-822. doi: 10.1080/00016489.2017.1295468. Epub 2017 Mar 16. PMID: 28301961.

Wrong study design

Peled C, Parra A, El-Saied S, Kraus M, Kaplan DM. Surgery for necrotizing otitis externa-indications and surgical findings. Eur Arch Otorhinolaryngol. 2020 May;277(5):1327-1334. doi: 10.1007/s00405-020-05842-x. Epub 2020 Feb 12. PMID: 32052142.

No comparison made

Beoordelingsdatum en geldigheid

Laatst beoordeeld  : 25-09-2025

Initiatief en autorisatie

Initiatief:
  • Nederlandse Vereniging voor Keel-Neus-Oorheelkunde en Heelkunde van het Hoofd-Halsgebied
Geautoriseerd door:
  • Nederlandse Internisten Vereniging
  • Nederlandse Vereniging voor Keel-Neus-Oorheelkunde en Heelkunde van het Hoofd-Halsgebied
  • Nederlandse Vereniging voor Medische Microbiologie
  • Nederlandse Vereniging voor Nucleaire geneeskunde
  • Nederlandse Vereniging voor Radiologie
  • Nederlandse Vereniging van Ziekenhuisapothekers
  • Hoormij / Nederlandse Vereniging voor Slechthorenden

Algemene gegevens

For more details on the guideline methodology used, we refer you to the Werkwijze. Relevant information for the development of this guideline is presented below.

 

The revision of this guideline module was supported by the Knowledge Institute of the Federation of Medical Specialists (www.demedischspecialist.nl/kennisinstituut) and was funded by the Quality Funds for Medical Specialists (SKMS).

Samenstelling werkgroep

For the development of the guideline, a multidisciplinary guideline development group was established in 2022, consisting of representatives from all relevant specialties (see Composition of the working group) involved in the care of patients with necrotizing otitis externa.

 

Werkgroep

  • Dr. J.J. (Jérôme) Waterval (chairman), Nederlandse Vereniging voor Keel-Neus-Oorheelkunde en Heelkunde van het Hoofd-Halsgebied, otorhinolaryngologist, Maastricht University Medical Center, Maastricht; Academic Alliance Skull Base Pathology Maaastricht University Medical Center – Radboud University Medical Center
  • Dr. M.J. (Mark) van Tilburg, Nederlandse Vereniging voor Keel-Neus-Oorheelkunde en Heelkunde van het Hoofd-Halsgebied, otorhinolaryngologist, Elistabeth-TweeSteden Ziekenhuis, Tilburg
  • Drs. S.A.H. (Sjoert) Pegge, Nederlandse Vereniging voor Radiologie, radiologist, Radboud University Medical Center, Nijmegen; Academic Alliance Skull Base Pathology Maaastricht University Medical Center – Radboud University Medical Center
  • Prof. Dr. A.W.J.M. (Andor) Glaudemans, Nederlandse Vereniging voor Nucleaire Geneeskunde, nuclear physicist UMCG, Groningen
  • Dr. M. (Moniek) Heusinkveld, Nederlandse Vereniging voor Medische Microbiologie, medical microbiologist, Gelderse Vallei Hospital, Ede
  • Dr. E.J.G. (Edgar) Peters, Nederlandse Internisten Vereniging, infectious disease specialist, Amsterdam University Medical Center (tot oktober 2022)
  • Dr. J.J. (Jonne) Sikkens, Nederlandse Internisten Vereniging, infectious disease specialist, Amsterdam University Medical Center (vanaf october 2022)
  • Dr. I.R. (Raluca) Mihailescu, Nederlandse Internisten Vereniging, infectious disease specialist, Onze Lieve Vrouwe Gasthuis, Amsterdam (vanaf juli 2024)
  • Dr. S.H. (Selwyn) Lowe, Nederlandse Internisten Vereniging, infectious disease specialist, Maastricht University Medical Center, Maastricht (vanaf juli 2024)

 Klankbordgroep

  • Dr. N.G.L. (Nynke) Jager, NVZA, hospital pharmacist Radboud University Medical Center, Nijmegen
  • Drs. F.S. (Fleur) Sinkeler, NVZA, hospital pharmacist Radboudumc Nijmegen

Ondersteuning

  • Drs. J.M.H. (Jasper) Janssen, NVKNO, otorhinolaryngologist in training, Maastricht University Medical Center, Maastricht
  • Dr. A. (Anja) van der Hout, advisor Knowledge Institute of the Dutch Association of Medical Specialists

Belangenverklaringen

An overview of the conflicts of interests of the guideline development group members and the assessment of how potential conflicts of interest were addressed can be found in the table below. The signed declarations of interest are available upon request from the Secretariat of the Knowledge Institute of the Dutch Federation of Medical Specialists at secretariaat@kennisinstituut.nl.

Werkgroeplid

Functie

Nevenfuncties

Gemelde belangen

Ondernomen actie

Waterval (voorzitter)

KNO-arts MUMC

Accreditatiecommissie Stichting Audiciensregister

Geen

Geen

Glaudemans

Nucleair geneeskundige UMCG

 

Voorzitter NVNG (onbetaald)

We hebben als ziekenhuis en afdeling een samenwerking met Siemens (UMCG-Siemens PUSH collaboration/Partnership of UMCG-Siemens for building the future of Health). Hieruit vloeit uit voort dat de nieuwste camera’s bij ons komen (bv UMCG neemt nieuwe Whole-Body PET/CT-scanner in gebruik) en dat er gezamenlijk onderzoek gedaan wordt. Hierbij heb ik een aantal promovendi die door Siemens betaald worden (niet op het gebied van osteomyelitis schedelbasis)

Geen restricties. Extern gefinancierd onderzoek valt buiten bestek richtlijn

 

Heusinkveld

Arts-microbioloog in ziekenhuis Gelders Vallei

Richtlijn otitis externa

 

Bestuur SKML sectie infectieserologie (onbetaald)

Geen

Geen

Peters (tot oktober 2022)

Internist-infectioloog-acute geneeskundige, Amsterdam UMC

richtlijnontwikkeling: Covid-19 FMS, diabetische voet NIV, diabetische voet IWGDF, alle onbetaald
Organisatie internationaal congres diabetische voet. Onbetaald

 

afdeling krijgt geld van Roche voor biomarker onderzoek bij diabetische voet osteomyelitis
Voorzitter gewrichtsprothese geassocieerde infectie richtlijn.

Diabetische voet onderzoek (extern gefinancierd)

 

Geen restricties. Extern gefinancierd onderzoek valt buiten bestek richtlijn

 

Pegge

Radioloog (Neuro/Hoofdhals)

Radboud UMC Nijmegen

Geen

Geen

Geen

Van Tilburg

KNO-arts ETZ

 

Geen

Geen

Geen

Sikkens

Internist acute geneeskunde & infectioloog, Amsterdam UMC

post-doc onderzoeker Amsterdam UMC, onbetaald

 

Ja, via ZonMw (onderzoek naar COVID bij een medewerkerscohort, onderwerp infectiepreventie en vaccin-immunologie)

 

Geen restricties. Extern gefinancierd onderzoek valt buiten bestek richtlijn

 

Lowe

 

Internist-infectioloog. Afdeling Medische Microbiologie, Infectieziekten en Infectiepreventie (MMI), Maastricht UMC+

 

Geen

Geen

Geen

Mihailescu

 

Internist-infectioloog

OLVG

Amsterdam

Geen

Geen

Geen

Jasper Janssen

 

KNO-arts in opleiding bij het MUMC+ (0,8 FTE), promovendus (0,2 FTE).

Geen

Geen

Geen

Sinkeler

 

Ziekenhuisapotheker AmsterdamUMC

 

Geen

Geen

Geen

Jager

Ziekenhuisapotheker

 

Geen

Geen

Geen

Inbreng patiëntenperspectief

Attention was paid to the patient perspective by inviting Stichting Hoormij and Patiëntenfederatie Nederland for the invitational conference, and close contact with Stichting Hoormij during the development of the guideline. The report of this [see related products] was discussed in the guideline development group. The input obtained was taken into account when formulating the key questions, selecting the outcome measures, and drafting the considerations. The draft guideline was also submitted for comments to Stichting Hoormij and Patiëntenfederatie Nederland, and any comments received were reviewed and processed.

 

Kwalitatieve raming van mogelijke financiële gevolgen in het kader van de Wkkgz

Bij de richtlijnmodule voerde de werkgroep conform de Wet kwaliteit, klachten en geschillen zorg (Wkkgz) een kwalitatieve raming uit om te beoordelen of de aanbevelingen mogelijk leiden tot substantiële financiële gevolgen. Bij het uitvoeren van deze beoordeling is de richtlijnmodule op verschillende domeinen getoetst (zie het stroomschema bij Werkwijze).

Module

Uitkomst raming

Toelichting

Surgical treatment

geen financiële gevolgen

Uit de toetsing volgt dat de aanbeveling(en) niet breed toepasbaar zijn (<5.000 patiënten) en daarom naar verwachting geen substantiële financiële gevolgen zal hebben voor de collectieve uitgaven.

Zoekverantwoording

Algemene informatie

Cluster/richtlijn: Osteomyelitis schedelbasis – maligne otitis externa

Uitgangsvraag/modules: Wat is de waarde van chirurgische behandeling bij maligne otitis externa, ten opzichte van alleen medicamenteuze behandeling?

Database(s): Ovid/Medline, Embase.com

Datum: 6 februari 2023

Periode: 2000* - heden

Talen: Engels, Nederlands

Literatuurspecialist: Miriam van der Maten

BMI-zoekblokken: voor verschillende opdrachten wordt (deels) gebruik gemaakt van de zoekblokken van BMI-Online https://blocks.bmi-online.nl/ Bij gebruikmaking van een volledig zoekblok zal naar de betreffende link op de website worden verwezen.

Toelichting:

Voor deze vraag is gezocht op de elementen:

  • Maligne otitis externa of osteomyelitis schedel
  • Chirurgische behandeling

→ De opgegeven sleutelartikelen worden gevonden met de zoekopdracht

→ Er is gezocht met major/focus Emtree/MeSH en in titel/keyword i.p.v. titel/abstract/keyword om ruis eruit te filteren.

 

*Er is gezocht vanaf het jaar 2000. Terugkomend op de opmerking van het zoekformulier, verder terugzoeken zal minimaal 250 hits extra betekenen.

Te gebruiken voor richtlijnen tekst:

Nederlands

In de databases Embase.com en Ovid/Medline is op 6 februari 2023 systematisch gezocht naar systematische reviews, RCT, observationele studies, niet-vergelijkend onderzoek over de waarde van chirurgische behandeling bij maligne otitis externa. De literatuurzoekactie leverde 456 unieke treffers op.

 

Engels

On the 6th of February 2023, we performed a systematic search in the databases Embase.com and Ovid/Medline to find systematic reviews, RCT, observational studies, and other non-comparative research about the value of surgical treatment for malignant external otitis. The search resulted in 456 unique hits.

Zoekopbrengst

 

EMBASE

OVID/MEDLINE

Ontdubbeld

SRs

14

14

21

Overige designs

234

325

435

Totaal

248

339

456

Zoekstrategie

Embase.com

No.

Query

Results

#10

#8 OR #9

248

#9

#6 NOT #8 = overige designs

234

#8

#6 AND #7 = SR

14

#7

'meta analysis'/exp OR 'meta analysis (topic)'/exp OR metaanaly*:ti,ab OR 'meta analy*':ti,ab OR metanaly*:ti,ab OR 'systematic review'/de OR 'cochrane database of systematic reviews'/jt OR prisma:ti,ab OR prospero:ti,ab OR (((systemati* OR scoping OR umbrella OR 'structured literature') NEAR/3 (review* OR overview*)):ti,ab) OR ((systemic* NEAR/1 review*):ti,ab) OR (((systemati* OR literature OR database* OR 'data base*') NEAR/10 search*):ti,ab) OR (((structured OR comprehensive* OR systemic*) NEAR/3 search*):ti,ab) OR (((literature NEAR/3 review*):ti,ab) AND (search*:ti,ab OR database*:ti,ab OR 'data base*':ti,ab)) OR (('data extraction':ti,ab OR 'data source*':ti,ab) AND 'study selection':ti,ab) OR ('search strategy':ti,ab AND 'selection criteria':ti,ab) OR ('data source*':ti,ab AND 'data synthesis':ti,ab) OR medline:ab OR pubmed:ab OR embase:ab OR cochrane:ab OR (((critical OR rapid) NEAR/2 (review* OR overview* OR synthes*)):ti) OR ((((critical* OR rapid*) NEAR/3 (review* OR overview* OR synthes*)):ab) AND (search*:ab OR database*:ab OR 'data base*':ab)) OR metasynthes*:ti,ab OR 'meta synthes*':ti,ab

898726

#6

#4 AND #5 AND [2000-2023]/py NOT ('conference abstract'/it OR 'editorial'/it OR 'letter'/it OR 'note'/it) NOT (('animal experiment'/exp OR 'animal model'/exp OR 'nonhuman'/exp) NOT 'human'/exp)

248

#5

'surgery'/exp/mj OR 'surgical patient'/exp/mj OR 'surgical risk'/exp/mj OR 'perioperative period'/exp/mj OR surgic*:ti,kw OR surger*:ti,kw OR operation*:ti,kw OR operative:ti,kw OR presurg*:ti,kw OR preoperati*:ti,kw OR 'pre-surg*':ti,kw OR 'pre-operati*':ti,kw OR perisurg*:ti,kw OR perioperati*:ti,kw OR 'peri-surg*':ti,kw OR 'peri-operati*':ti,kw OR postsurg*:ti,kw OR postoperati*:ti,kw OR 'post-surg*':ti,kw OR 'post-operati*':ti,kw OR 'debridement'/exp OR 'debridement':ti,ab,kw OR resect*:ti,ab,kw OR mastoidectom*:ti,ab,kw

3894874

#4

'malignant otitis externa'/exp/mj OR (((maligna* OR necroti* OR necrosis) NEAR/3 ('otitis externa' OR 'external otitis')):ti,kw) OR ('otitis externa'/mj AND (maligna*:ti,kw OR necroti*:ti,kw OR necrosis:ti,kw)) OR (('osteomyelitis'/exp/mj OR 'osteomyelitis':ti,kw) AND ('skull'/exp/mj OR 'skull disease'/exp/mj OR skull*:ti,ab,kw OR cranial:ti,ab,kw OR cranium:ti,ab,kw))

3086

Ovid/Medline

#

Searches

Results

9

7 or 8

339

8

5 not 7= overige designs

325

7

5 and 6 = SR

14

6

meta-analysis/ or meta-analysis as topic/ or (metaanaly* or meta-analy* or metanaly*).ti,ab,kf. or systematic review/ or cochrane.jw. or (prisma or prospero).ti,ab,kf. or ((systemati* or scoping or umbrella or "structured literature") adj3 (review* or overview*)).ti,ab,kf. or (systemic* adj1 review*).ti,ab,kf. or ((systemati* or literature or database* or data-base*) adj10 search*).ti,ab,kf. or ((structured or comprehensive* or systemic*) adj3 search*).ti,ab,kf. or ((literature adj3 review*) and (search* or database* or data-base*)).ti,ab,kf. or (("data extraction" or "data source*") and "study selection").ti,ab,kf. or ("search strategy" and "selection criteria").ti,ab,kf. or ("data source*" and "data synthesis").ti,ab,kf. or (medline or pubmed or embase or cochrane).ab. or ((critical or rapid) adj2 (review* or overview* or synthes*)).ti. or (((critical* or rapid*) adj3 (review* or overview* or synthes*)) and (search* or database* or data-base*)).ab. or (metasynthes* or meta-synthes*).ti,ab,kf.

650866

5

limit 4 to yr="2000 -Current"

339

4

3 not (comment/ or editorial/ or letter/ or ((exp animals/ or exp models, animal/) not humans/))

580

3

1 and 2

606

2

exp *Surgical Procedures, Operative/ or exp *Specialties, Surgical/ or exp *Perioperative Period/ or surgic*.ti,kf. or surger*.ti,kf. or operation*.ti,kf. or operative.ti,kf. or presurg*.ti,kf. or preoperati*.ti,kf. or pre-surg*.ti,kf. or pre-operati*.ti,kf. or perisurg*.ti,kf. or perioperati*.ti,kf. or peri-surg*.ti,kf. or peri-operati*.ti,kf. or postsurg*.ti,kf. or postoperati*.ti,kf. or post-surg*.ti,kf. or post-operati*.ti,kf. or exp Debridement/ or 'debridement'.ti,ab,kf. or resect*.ti,ab,kf. or mastoidectom*.ti,ab,kf.

3205775

1

((maligna* or necroti* or necrosis) adj3 ('otitis externa' or 'external otitis')).ti,kf. or (exp *Otitis Externa/ and (maligna* or necroti* or necrosis).ti,kf.) or ((exp *Osteomyelitis/ or 'osteomyelitis'.ti,kf.) and (exp Skull/ or skull*.ti,ab,kf. or cranial.ti,ab,kf. or cranium.ti,ab,kf.))

2625

Volgende:
Hyperbaric oxygen therapy